Search

everythinglearnresearchcommunity

for

Search:↓

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Researchers developed a quick and sensitive way to measure finasteride in blood using a small sample size.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Four-amino acid part makes enzyme sensitive to finasteride.

Higher fluoride levels may delay puberty in boys.

A systematic approach is crucial for managing hair loss in women.

Cytochrome P-450 enzymes in the skin help break down various substances and could be targeted to treat skin conditions.

Annurca apple supplement safely increases hair growth and keratin in humans.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

Platelet-rich plasma therapy helps increase hair density in male patients with hair loss but doesn't change hair thickness.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

The document concludes that both internal stem cell factors and external influences like the environment and hormones affect hair loss and aging, with potential treatments focusing on these areas.

Finasteride harms invertebrates' survival and burial ability.

Serenoa repens may cause early puberty and should be used cautiously in children.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormone levels in hair change during pregnancy, with progesterone increasing significantly compared to non-pregnant women.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

ERG increases SOX9, promoting prostate cancer growth and invasion.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.